Abstract:Background: MicroRNA-7 (miR-7) has been reported to be a tumour suppressor gene. However, whether it has a role in the growth of non-small-cell lung cancer (NSCLC) and what is its target involved in the tumour growth is still under investigation. Methods: NSCLC tissue sample, NSCLC cell lines and tissue microarray were investigated in this study. Total RNA, miRNA and protein were used for RT-PCR and western blot analysis. Immunohistochemistry was performed in tissues microarray. Cell culture and intervention experiments were performed in vitro and in vivo . Bioinformatics prediction, western blot and luciferase assay were identified the target of miR-7. Results: In this study, we found that the expression of miR-7 was significantly downregulated not only in NSCLC cell lines, but also in human NSCLC tissues compared with the matched adjacent tissues. Restoration of its expression through miR-7 mimics in A549 and H1299 NSCLC cells inhibited cell proliferation, colony formation, and cell-cycle progression in vitro. More importantly, the tumorigenicity in nude mice was reduced after administration of miR-7 in vivo . In advance, through bioinformatic analysis, luciferase assay and western blot, we identified a novel target of miR-7, PA28gamma (a proteasome activator) to be enrolled in the regulation with tumour. PA28gamma mRNA and protein levels are markedly upregulated in NSCLC cell lines and tumour samples, exhibiting a strong inverse relation with that of miR-7. In addition, knockdown of PA28gamma induced similar effects as overexpression of miR-7 in NSCLC cells. Furthermore, miR-7 overexpressio n or silencing of PA28gamma reduced the cyclinD1 expression at mRNA and protein level in NSCLC cell lines. Conclusion: All these findings strongly imply that the overexpression of PA28gamma resulted from miR-7 downexpression in NSCLC has an important role in promoting cancer cell progress and consequently results in NSCLC growth. Thus, strategies targeting PA28gamma and/or miR-7 may become promising molecular therapies in NSCLC treatment.

MicroRNA-7 Inhibits the Growth of Human Non-Small Cell Lung Cancer A549 Cells Through Targeting BCL-2.

PA28gamma Emerges As a Novel Functional Target of Tumour Suppressor Microrna-7 in Non-Small-cell Lung Cancer

Microrna-7 Inhibits the Malignant Phenotypes of Non-Small Cell Lung Cancer in Vitro by Targeting Pax6

Docetaxel Inhibits the Proliferation of Non-Small-cell Lung Cancer Cells Via Upregulation of Microrna-7 Expression.

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

MicroRNA-15a Induces Cell Apoptosis and Inhibits Metastasis by Targeting BCL2L2 in Non-Small Cell Lung Cancer

Bio-Engineered MicroRNA-7 is Effective to Interfere with Akt3/p53 Axis and Suppress Human Non-Small Cell Lung Cancer

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway

Mir‑654‑3p Suppresses Cell Viability and Promotes Apoptosis by Targeting RASAL2 in Non‑small‑cell Lung Cancer.

microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.

miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2

Cirs-7 Targeting Mir-7 Modulates The Progression Of Non-Small Cell Lung Cancer In A Manner Dependent On Nf-Kappa B Signalling

MicroRNA-17-5p Inhibits Proliferation and Triggers Apoptosis in Non-Small Cell Lung Cancer by Targeting Transforming Growth Factor Β Receptor 2.

MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line

MicroRNA-30a Suppresses Non-Small-cell Lung Cancer by Targeting Myb-related Protein B.

MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6

Mir-497-5p Inhibits Tumor Cell Growth and Invasion by Targeting SOX5 in Non-Small-cell Lung Cancer

Suppression of CX3CL1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells

MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)

MicroRNA-7 Sensitizes Non-Small Cell Lung Cancer Cells to Paclitaxel.